111 related articles for article (PubMed ID: 36264138)
1. Pharmacological inhibition of cathepsin C (CatC) as a potential approach for cancer therapeutics.
Abideen SA; Khan M; Al-Harbi AI; Ahmad S
J Biomol Struct Dyn; 2023; 41(18):8682-8689. PubMed ID: 36264138
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin C inhibition as a potential treatment strategy in cancer.
Korkmaz B; Lamort AS; Domain R; Beauvillain C; Gieldon A; Yildirim AÖ; Stathopoulos GT; Rhimi M; Jenne DE; Kettritz R
Biochem Pharmacol; 2021 Dec; 194():114803. PubMed ID: 34678221
[TBL] [Abstract][Full Text] [Related]
3. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
[TBL] [Abstract][Full Text] [Related]
4. Systemic computational investigation to identify potential inhibitors against cancer by targeting P21-activated kinase 4 and D(CGATCG).
Ahmed AH; Jassim TS; Ali RW; Hameed AR; Alfalki AM
J Biomol Struct Dyn; 2023 Nov; 41(19):9356-9365. PubMed ID: 36326467
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential drug molecules against fibroblast growth factor receptor 3 (FGFR3) by multi-stage computational-biophysics correlate.
Ahmad S; Almanaa TN; Khan S; Aljahdali SM; Waheed Y; Aljasir MA; Al-Megrin WAI; Aziz A; Ateeq M; Amin F; Khattak SU; Sanami S
J Biomol Struct Dyn; 2023 Dec; ():1-9. PubMed ID: 38064307
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of cathepsin C: from pathophysiology to treatment.
Korkmaz B; Caughey GH; Chapple I; Gauthier F; Hirschfeld J; Jenne DE; Kettritz R; Lalmanach G; Lamort AS; Lauritzen C; Łȩgowska M; Lesner A; Marchand-Adam S; McKaig SJ; Moss C; Pedersen J; Roberts H; Schreiber A; Seren S; Thakker NS
Pharmacol Ther; 2018 Oct; 190():202-236. PubMed ID: 29842917
[TBL] [Abstract][Full Text] [Related]
7. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.
Seren S; Rashed Abouzaid M; Eulenberg-Gustavus C; Hirschfeld J; Nasr Soliman H; Jerke U; N'Guessan K; Dallet-Choisy S; Lesner A; Lauritzen C; Schacher B; Eickholz P; Nagy N; Szell M; Croix C; Viaud-Massuard MC; Al Farraj Aldosari A; Ragunatha S; Ibrahim Mostafa M; Giampieri F; Battino M; Cornillier H; Lorette G; Stephan JL; Goizet C; Pedersen J; Gauthier F; Jenne DE; Marchand-Adam S; Chapple IL; Kettritz R; Korkmaz B
J Biol Chem; 2018 Aug; 293(32):12415-12428. PubMed ID: 29925593
[TBL] [Abstract][Full Text] [Related]
8. A cheminformatics-biophysics correlate to identify promising lead molecules against matrix metalloproteinase-2 (MMP-2) enzyme: A promising anti-cancer target.
Alrumaihi F
Saudi Pharm J; 2023 Jul; 31(7):1244-1253. PubMed ID: 37284415
[TBL] [Abstract][Full Text] [Related]
9. Deciphering
Alghamdi MA; Azam F; Alam P
J Biomol Struct Dyn; 2024 Jan; ():1-17. PubMed ID: 38230450
[TBL] [Abstract][Full Text] [Related]
10. A hierarchical approach towards identification of novel inhibitors against L, D-transpeptidase YcbB as an anti-bacterial therapeutic target.
Alawam AS; M Alneghery L; Alwethaynani MS; Alamri MA
J Biomol Struct Dyn; 2024 Feb; ():1-11. PubMed ID: 38411016
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C.
Korkmaz B; Lesner A; Wysocka M; Gieldon A; Håkansson M; Gauthier F; Logan DT; Jenne DE; Lauritzen C; Pedersen J
Biochem Pharmacol; 2019 Jun; 164():349-367. PubMed ID: 30978322
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
Purohit P; Dash JJ; Muya JT; Meher BR
J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
[TBL] [Abstract][Full Text] [Related]
13. Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
Korkmaz B; Lesner A; Marchand-Adam S; Moss C; Jenne DE
J Med Chem; 2020 Nov; 63(22):13258-13265. PubMed ID: 32692176
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 2 is a druggable target against glioblastoma: A computational investigation.
Siddique R; Abideen SA; Nabi G; Awan FM; Noor Khan S; Ullah F; Khan S; Xue M
Front Chem; 2022; 10():1071929. PubMed ID: 36505741
[TBL] [Abstract][Full Text] [Related]
15. Targeting Cathepsin C in PR3-ANCA Vasculitis.
Jerke U; Eulenberg-Gustavus C; Rousselle A; Nicklin P; Kreideweiss S; Grundl MA; Eickholz P; Nickles K; Schreiber A; Korkmaz B; Kettritz R
J Am Soc Nephrol; 2022 May; 33(5):936-947. PubMed ID: 35292437
[TBL] [Abstract][Full Text] [Related]
16. A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against
Al-Harbi AI; Ullah A; Almanaa TN; Gul F; Khan S; Waheed Y; Ul Haq M; Muhammad R; Khurram M; Ullah A; Ahmad S
J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37551016
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 M
Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca
Liu Q; Zhang Y; Liu S; Liu Y; Yang X; Liu G; Shimizu T; Ikenaka K; Fan K; Ma J
J Neuroinflammation; 2019 Jan; 16(1):10. PubMed ID: 30651105
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
20. Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases.
Hamon Y; Legowska M; Hervé V; Dallet-Choisy S; Marchand-Adam S; Vanderlynden L; Demonte M; Williams R; Scott CJ; Si-Tahar M; Heuzé-Vourc'h N; Lalmanach G; Jenne DE; Lesner A; Gauthier F; Korkmaz B
J Biol Chem; 2016 Apr; 291(16):8486-99. PubMed ID: 26884336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
